A new type of nanoparticle can be administered to the lungs, where it can deliver messenger RNA encoding useful proteins. Researchers hope to use them to develop new treatments for cystic fibrosis and other lung diseases.
Revolutionizing CRISPR: Quantum Biology and AI Merge to Enhance Genome Editing
Breakthrough gene silencing method slashes cholesterol for a year in mice, no DNA damage
nanoparticles – Penn Bioengineering Blog
New Cas9 mouse model will be easier to CRISPR gene-edit and enable faster progress against diseases like cancer
Combinatorial design of nanoparticles for pulmonary mRNA delivery and genome editing
New nanoparticles can perform gene editing in the lungs, MIT News
Genetic Engineering 2.0: An On-Off Switch for Gene Editing
Inhaled Carrier May Work for CF mRNA Therapy, Mouse Study Finds
Combinatorial design of nanoparticles for pulmonary mRNA delivery and genome editing
Nanoparticles used to deliver CRISPR gene editing tools into the cell
Nanoparticles can Perform Gene-editing in the Lungs - The Indian Practitioner
Lung SORT LNPs enable precise homology-directed repair mediated CRISPR/Cas genome correction in cystic fibrosis models
New nanoparticles can perform gene editing in the lungs, MIT News
Oscar R. Miranda, PhD/MBA/BE (He/Him) on LinkedIn: New nanoparticles can perform gene editing in the lungs
MIT scientists develop new nanoparticles to improve vaccine delivery